GO:0031224 | intrinsic component of membrane | 24.17% (29/120) | 1.4 | 1e-06 | 0.000438 |
GO:1902532 | negative regulation of intracellular signal transduction | 8.33% (10/120) | 2.93 | 1e-06 | 0.000468 |
GO:0005789 | endoplasmic reticulum membrane | 13.33% (16/120) | 2.29 | 0.0 | 0.000483 |
GO:0006810 | transport | 27.5% (33/120) | 1.31 | 1e-06 | 0.000496 |
GO:0016021 | integral component of membrane | 22.5% (27/120) | 1.49 | 1e-06 | 0.000506 |
GO:0031300 | intrinsic component of organelle membrane | 7.5% (9/120) | 3.05 | 2e-06 | 0.000589 |
GO:0051234 | establishment of localization | 28.33% (34/120) | 1.29 | 0.0 | 0.000659 |
GO:1901223 | negative regulation of NIK/NF-kappaB signaling | 2.5% (3/120) | 6.76 | 2e-06 | 0.000685 |
GO:0016020 | membrane | 48.33% (58/120) | 0.78 | 2e-06 | 0.000747 |
GO:1902531 | regulation of intracellular signal transduction | 11.67% (14/120) | 2.17 | 3e-06 | 0.000807 |
GO:0051179 | localization | 29.17% (35/120) | 1.13 | 4e-06 | 0.00097 |
GO:0031984 | organelle subcompartment | 12.5% (15/120) | 2.03 | 4e-06 | 0.001008 |
GO:0090387 | phagolysosome assembly involved in apoptotic cell clearance | 1.67% (2/120) | 8.35 | 9e-06 | 0.001895 |
GO:0098791 | Golgi apparatus subcompartment | 10.0% (12/120) | 2.23 | 1e-05 | 0.001967 |
GO:0005795 | Golgi stack | 3.33% (4/120) | 4.76 | 1.5e-05 | 0.002602 |
GO:0048522 | positive regulation of cellular process | 28.33% (34/120) | 1.03 | 2.5e-05 | 0.003899 |
GO:0044297 | cell body | 5.83% (7/120) | 3.04 | 2.5e-05 | 0.004122 |
GO:0006895 | Golgi to endosome transport | 2.5% (3/120) | 5.47 | 4.2e-05 | 0.004391 |
GO:0110165 | cellular anatomical entity | 77.5% (93/120) | 0.37 | 4.4e-05 | 0.004419 |
GO:0055100 | adiponectin binding | 1.67% (2/120) | 7.35 | 5.6e-05 | 0.004462 |
GO:0061042 | vascular wound healing | 1.67% (2/120) | 7.35 | 5.6e-05 | 0.004462 |
GO:0097003 | adipokinetic hormone receptor activity | 1.67% (2/120) | 7.35 | 5.6e-05 | 0.004462 |
GO:0052325 | cell wall pectin biosynthetic process | 3.33% (4/120) | 4.39 | 4.1e-05 | 0.00451 |
GO:0030100 | regulation of endocytosis | 5.0% (6/120) | 3.17 | 5.9e-05 | 0.004569 |
GO:0005575 | cellular_component | 78.33% (94/120) | 0.36 | 4e-05 | 0.004621 |
GO:0046321 | positive regulation of fatty acid oxidation | 2.5% (3/120) | 5.41 | 4.8e-05 | 0.004665 |
GO:0031399 | regulation of protein modification process | 10.83% (13/120) | 1.93 | 4e-05 | 0.004753 |
GO:0010648 | negative regulation of cell communication | 11.67% (14/120) | 1.79 | 5.4e-05 | 0.004762 |
GO:0031410 | cytoplasmic vesicle | 15.0% (18/120) | 1.52 | 5.1e-05 | 0.004815 |
GO:0023057 | negative regulation of signaling | 11.67% (14/120) | 1.8 | 5.3e-05 | 0.004847 |
GO:0031301 | integral component of organelle membrane | 5.83% (7/120) | 2.94 | 3.9e-05 | 0.00489 |
GO:0050794 | regulation of cellular process | 46.67% (56/120) | 0.68 | 3.8e-05 | 0.004977 |
GO:0009968 | negative regulation of signal transduction | 11.67% (14/120) | 1.84 | 3.8e-05 | 0.005217 |
GO:0048518 | positive regulation of biological process | 32.5% (39/120) | 0.91 | 3.6e-05 | 0.005294 |
GO:0097708 | intracellular vesicle | 15.0% (18/120) | 1.48 | 7.3e-05 | 0.005515 |
GO:0010906 | regulation of glucose metabolic process | 3.33% (4/120) | 4.14 | 8.2e-05 | 0.005565 |
GO:0001933 | negative regulation of protein phosphorylation | 4.17% (5/120) | 3.49 | 8.9e-05 | 0.005565 |
GO:0010289 | homogalacturonan biosynthetic process | 2.5% (3/120) | 5.18 | 7.8e-05 | 0.005572 |
GO:0090306 | meiotic spindle assembly | 2.5% (3/120) | 5.18 | 7.8e-05 | 0.005572 |
GO:0005768 | endosome | 11.67% (14/120) | 1.74 | 8.1e-05 | 0.005587 |
GO:0000139 | Golgi membrane | 7.5% (9/120) | 2.32 | 8.8e-05 | 0.005683 |
GO:0005856 | cytoskeleton | 7.5% (9/120) | 2.32 | 8.8e-05 | 0.005683 |
GO:0016500 | protein-hormone receptor activity | 1.67% (2/120) | 7.03 | 9.3e-05 | 0.005695 |
GO:0012506 | vesicle membrane | 8.33% (10/120) | 2.14 | 0.000101 | 0.006035 |
GO:0120162 | positive regulation of cold-induced thermogenesis | 2.5% (3/120) | 5.03 | 0.000108 | 0.006179 |
GO:0051649 | establishment of localization in cell | 12.5% (15/120) | 1.63 | 0.000107 | 0.006239 |
GO:0010394 | homogalacturonan metabolic process | 2.5% (3/120) | 4.98 | 0.000119 | 0.00668 |
GO:0006650 | glycerophospholipid metabolic process | 5.0% (6/120) | 2.97 | 0.000128 | 0.007037 |
GO:0023051 | regulation of signaling | 18.33% (22/120) | 1.24 | 0.000135 | 0.007141 |
GO:0009966 | regulation of signal transduction | 17.5% (21/120) | 1.28 | 0.000135 | 0.007284 |
GO:0010646 | regulation of cell communication | 18.33% (22/120) | 1.23 | 0.00015 | 0.007614 |
GO:0048585 | negative regulation of response to stimulus | 15.0% (18/120) | 1.4 | 0.000153 | 0.007617 |
GO:0001932 | regulation of protein phosphorylation | 6.67% (8/120) | 2.4 | 0.00015 | 0.007762 |
GO:0000212 | meiotic spindle organization | 2.5% (3/120) | 4.76 | 0.000187 | 0.008503 |
GO:0120161 | regulation of cold-induced thermogenesis | 2.5% (3/120) | 4.76 | 0.000187 | 0.008503 |
GO:0042326 | negative regulation of phosphorylation | 4.17% (5/120) | 3.27 | 0.000182 | 0.008552 |
GO:0019222 | regulation of metabolic process | 33.33% (40/120) | 0.79 | 0.000179 | 0.008563 |
GO:0046486 | glycerolipid metabolic process | 5.83% (7/120) | 2.59 | 0.000177 | 0.008659 |
GO:0048519 | negative regulation of biological process | 28.33% (34/120) | 0.88 | 0.000203 | 0.009081 |
GO:0051239 | regulation of multicellular organismal process | 18.33% (22/120) | 1.19 | 0.000213 | 0.009344 |
GO:0098563 | intrinsic component of synaptic vesicle membrane | 2.5% (3/120) | 4.68 | 0.00022 | 0.009357 |
GO:0031090 | organelle membrane | 25.0% (30/120) | 0.96 | 0.000217 | 0.009389 |
GO:0045489 | pectin biosynthetic process | 4.17% (5/120) | 3.18 | 0.000243 | 0.009719 |
GO:0033211 | adiponectin-activated signaling pathway | 1.67% (2/120) | 6.35 | 0.000259 | 0.009737 |
GO:0055090 | acylglycerol homeostasis | 1.67% (2/120) | 6.35 | 0.000259 | 0.009737 |
GO:0070328 | triglyceride homeostasis | 1.67% (2/120) | 6.35 | 0.000259 | 0.009737 |
GO:1901222 | regulation of NIK/NF-kappaB signaling | 2.5% (3/120) | 4.65 | 0.000238 | 0.009798 |
GO:0051641 | cellular localization | 15.0% (18/120) | 1.34 | 0.000243 | 0.00984 |
GO:0031982 | vesicle | 15.0% (18/120) | 1.35 | 0.000236 | 0.009888 |
GO:0070925 | organelle assembly | 6.67% (8/120) | 2.28 | 0.000257 | 0.010122 |
GO:0046907 | intracellular transport | 10.83% (13/120) | 1.64 | 0.000278 | 0.010193 |
GO:0071702 | organic substance transport | 15.0% (18/120) | 1.33 | 0.000275 | 0.010212 |
GO:0050789 | regulation of biological process | 49.17% (59/120) | 0.55 | 0.000287 | 0.010373 |
GO:0048523 | negative regulation of cellular process | 22.5% (27/120) | 1.01 | 0.000298 | 0.010458 |
GO:0046320 | regulation of fatty acid oxidation | 2.5% (3/120) | 4.54 | 0.000297 | 0.010573 |
GO:0008150 | biological_process | 76.67% (92/120) | 0.32 | 0.000309 | 0.010593 |
GO:0007268 | chemical synaptic transmission | 2.5% (3/120) | 4.51 | 0.000318 | 0.010623 |
GO:0098916 | anterograde trans-synaptic signaling | 2.5% (3/120) | 4.51 | 0.000318 | 0.010623 |
GO:0043229 | intracellular organelle | 55.83% (67/120) | 0.48 | 0.000307 | 0.010635 |
GO:0060055 | angiogenesis involved in wound healing | 1.67% (2/120) | 6.18 | 0.000332 | 0.010665 |
GO:0051246 | regulation of protein metabolic process | 14.17% (17/120) | 1.35 | 0.000341 | 0.010706 |
GO:0030030 | cell projection organization | 5.83% (7/120) | 2.44 | 0.00033 | 0.010747 |
GO:0016740 | transferase activity | 27.5% (33/120) | 0.87 | 0.000328 | 0.010791 |
GO:0031164 | contractile vacuolar membrane | 2.5% (3/120) | 4.47 | 0.000341 | 0.010826 |
GO:0030659 | cytoplasmic vesicle membrane | 7.5% (9/120) | 2.05 | 0.00035 | 0.010854 |
GO:0099536 | synaptic signaling | 2.5% (3/120) | 4.44 | 0.000364 | 0.010916 |
GO:0099537 | trans-synaptic signaling | 2.5% (3/120) | 4.44 | 0.000364 | 0.010916 |
GO:0043226 | organelle | 55.83% (67/120) | 0.48 | 0.00037 | 0.010973 |
GO:0046903 | secretion | 5.0% (6/120) | 2.68 | 0.000379 | 0.011107 |
GO:0045184 | establishment of protein localization | 10.0% (12/120) | 1.69 | 0.000364 | 0.011168 |
GO:0042325 | regulation of phosphorylation | 6.67% (8/120) | 2.19 | 0.000401 | 0.011627 |
GO:0097208 | alveolar lamellar body | 1.67% (2/120) | 6.03 | 0.000414 | 0.011858 |
GO:0009987 | cellular process | 67.5% (81/120) | 0.37 | 0.000481 | 0.013636 |
GO:0019220 | regulation of phosphate metabolic process | 7.5% (9/120) | 1.97 | 0.00051 | 0.01415 |
GO:0044233 | mitochondria-associated endoplasmic reticulum membrane | 1.67% (2/120) | 5.89 | 0.000505 | 0.014157 |
GO:0007265 | Ras protein signal transduction | 2.5% (3/120) | 4.26 | 0.000528 | 0.01449 |
GO:0048583 | regulation of response to stimulus | 25.0% (30/120) | 0.88 | 0.000548 | 0.014891 |
GO:0051174 | regulation of phosphorus metabolic process | 7.5% (9/120) | 1.95 | 0.000571 | 0.015215 |
GO:0065007 | biological regulation | 51.67% (62/120) | 0.49 | 0.000567 | 0.015258 |
GO:0010563 | negative regulation of phosphorus metabolic process | 4.17% (5/120) | 2.88 | 0.000621 | 0.015741 |
GO:0045936 | negative regulation of phosphate metabolic process | 4.17% (5/120) | 2.88 | 0.000621 | 0.015741 |
GO:0008038 | neuron recognition | 1.67% (2/120) | 5.76 | 0.000605 | 0.015779 |
GO:0042599 | lamellar body | 1.67% (2/120) | 5.76 | 0.000605 | 0.015779 |
GO:0008104 | protein localization | 11.67% (14/120) | 1.45 | 0.000615 | 0.015888 |
GO:0031323 | regulation of cellular metabolic process | 28.33% (34/120) | 0.8 | 0.000642 | 0.015969 |
GO:0032879 | regulation of localization | 12.5% (15/120) | 1.38 | 0.000636 | 0.015969 |
GO:0003674 | molecular_function | 74.17% (89/120) | 0.31 | 0.000663 | 0.016325 |
GO:1903532 | positive regulation of secretion by cell | 3.33% (4/120) | 3.35 | 0.000672 | 0.016402 |
GO:0051047 | positive regulation of secretion | 3.33% (4/120) | 3.33 | 0.000712 | 0.017067 |
GO:0032502 | developmental process | 40.83% (49/120) | 0.6 | 0.000708 | 0.017131 |
GO:0052546 | cell wall pectin metabolic process | 3.33% (4/120) | 3.3 | 0.000754 | 0.017906 |
GO:0006644 | phospholipid metabolic process | 5.83% (7/120) | 2.23 | 0.000773 | 0.018043 |
GO:0015031 | protein transport | 9.17% (11/120) | 1.65 | 0.000784 | 0.018136 |
GO:1903530 | regulation of secretion by cell | 4.17% (5/120) | 2.81 | 0.000773 | 0.018183 |
GO:0018105 | peptidyl-serine phosphorylation | 4.17% (5/120) | 2.8 | 0.000803 | 0.018244 |
GO:0051049 | regulation of transport | 10.83% (13/120) | 1.48 | 0.000797 | 0.018272 |
GO:0042995 | cell projection | 10.0% (12/120) | 1.55 | 0.000846 | 0.019067 |
GO:0071705 | nitrogen compound transport | 12.5% (15/120) | 1.34 | 0.000885 | 0.019778 |
GO:0043231 | intracellular membrane-bounded organelle | 49.17% (59/120) | 0.49 | 0.000903 | 0.019829 |
GO:0043025 | neuronal cell body | 4.17% (5/120) | 2.76 | 0.000899 | 0.019914 |
GO:0005543 | phospholipid binding | 5.0% (6/120) | 2.43 | 0.000925 | 0.02015 |
GO:0036099 | female germ-line stem cell population maintenance | 1.67% (2/120) | 5.44 | 0.000956 | 0.020324 |
GO:0007018 | microtubule-based movement | 4.17% (5/120) | 2.74 | 0.00095 | 0.020363 |
GO:0018209 | peptidyl-serine modification | 4.17% (5/120) | 2.74 | 0.00095 | 0.020363 |
GO:0006996 | organelle organization | 16.67% (20/120) | 1.1 | 0.000975 | 0.020556 |
GO:0030141 | secretory granule | 3.33% (4/120) | 3.2 | 0.00099 | 0.020702 |
GO:0006796 | phosphate-containing compound metabolic process | 17.5% (21/120) | 1.05 | 0.001048 | 0.02175 |
GO:0046426 | negative regulation of receptor signaling pathway via JAK-STAT | 1.67% (2/120) | 5.35 | 0.00109 | 0.022111 |
GO:1904893 | negative regulation of receptor signaling pathway via STAT | 1.67% (2/120) | 5.35 | 0.00109 | 0.022111 |
GO:0043168 | anion binding | 17.5% (21/120) | 1.05 | 0.001085 | 0.022335 |
GO:0051046 | regulation of secretion | 4.17% (5/120) | 2.69 | 0.001117 | 0.022471 |
GO:0070726 | cell wall assembly | 1.67% (2/120) | 5.26 | 0.001233 | 0.023731 |
GO:0061087 | positive regulation of histone H3-K27 methylation | 1.67% (2/120) | 5.26 | 0.001233 | 0.023731 |
GO:0008543 | fibroblast growth factor receptor signaling pathway | 1.67% (2/120) | 5.26 | 0.001233 | 0.023731 |
GO:0080090 | regulation of primary metabolic process | 26.67% (32/120) | 0.78 | 0.001189 | 0.02375 |
GO:0016604 | nuclear body | 6.67% (8/120) | 1.94 | 0.001206 | 0.023894 |
GO:0043227 | membrane-bounded organelle | 49.17% (59/120) | 0.48 | 0.001227 | 0.02414 |
GO:0045335 | phagocytic vesicle | 3.33% (4/120) | 3.09 | 0.001304 | 0.024723 |
GO:0045995 | regulation of embryonic development | 3.33% (4/120) | 3.08 | 0.001335 | 0.024788 |
GO:0031400 | negative regulation of protein modification process | 5.0% (6/120) | 2.33 | 0.001317 | 0.024803 |
GO:0006793 | phosphorus metabolic process | 17.5% (21/120) | 1.03 | 0.001299 | 0.024821 |
GO:0043405 | regulation of MAP kinase activity | 2.5% (3/120) | 3.8 | 0.00133 | 0.024856 |
GO:0032482 | Rab protein signal transduction | 1.67% (2/120) | 5.18 | 0.001385 | 0.025526 |
GO:0120025 | plasma membrane bounded cell projection | 9.17% (11/120) | 1.55 | 0.001435 | 0.026082 |
GO:0005515 | protein binding | 51.67% (62/120) | 0.45 | 0.00143 | 0.026175 |
GO:0007030 | Golgi organization | 3.33% (4/120) | 3.04 | 0.001467 | 0.02649 |
GO:0019637 | organophosphate metabolic process | 9.17% (11/120) | 1.52 | 0.001619 | 0.029039 |
GO:0023052 | signaling | 3.33% (4/120) | 2.99 | 0.001682 | 0.029951 |
GO:0030952 | establishment or maintenance of cytoskeleton polarity | 1.67% (2/120) | 5.03 | 0.001713 | 0.030098 |
GO:0070727 | cellular macromolecule localization | 11.67% (14/120) | 1.3 | 0.001709 | 0.03023 |
GO:0051171 | regulation of nitrogen compound metabolic process | 25.0% (30/120) | 0.78 | 0.001764 | 0.030794 |
GO:0008092 | cytoskeletal protein binding | 6.67% (8/120) | 1.85 | 0.001789 | 0.031019 |
GO:0007163 | establishment or maintenance of cell polarity | 3.33% (4/120) | 2.96 | 0.001836 | 0.031226 |
GO:0035639 | purine ribonucleoside triphosphate binding | 13.33% (16/120) | 1.18 | 0.001813 | 0.031244 |
GO:0048878 | chemical homeostasis | 11.67% (14/120) | 1.29 | 0.001832 | 0.031353 |
GO:0098655 | cation transmembrane transport | 5.83% (7/120) | 2.01 | 0.001874 | 0.031658 |
GO:0097384 | cellular lipid biosynthetic process | 1.67% (2/120) | 4.96 | 0.001889 | 0.03172 |
GO:0006812 | cation transport | 7.5% (9/120) | 1.69 | 0.002028 | 0.033199 |
GO:0051050 | positive regulation of transport | 5.83% (7/120) | 1.99 | 0.002007 | 0.033279 |
GO:0007264 | small GTPase mediated signal transduction | 2.5% (3/120) | 3.59 | 0.002022 | 0.033315 |
GO:0046425 | regulation of receptor signaling pathway via JAK-STAT | 1.67% (2/120) | 4.89 | 0.002074 | 0.033335 |
GO:0098993 | anchored component of synaptic vesicle membrane | 1.67% (2/120) | 4.89 | 0.002074 | 0.033335 |
GO:0045859 | regulation of protein kinase activity | 4.17% (5/120) | 2.5 | 0.002006 | 0.033462 |
GO:0060627 | regulation of vesicle-mediated transport | 5.0% (6/120) | 2.2 | 0.002057 | 0.033467 |
GO:0036211 | protein modification process | 19.17% (23/120) | 0.91 | 0.002137 | 0.034138 |
GO:0006811 | ion transport | 10.0% (12/120) | 1.39 | 0.002185 | 0.034285 |
GO:0071900 | regulation of protein serine/threonine kinase activity | 3.33% (4/120) | 2.89 | 0.002174 | 0.034318 |
GO:0050790 | regulation of catalytic activity | 9.17% (11/120) | 1.47 | 0.002161 | 0.034318 |
GO:0010633 | negative regulation of epithelial cell migration | 1.67% (2/120) | 4.82 | 0.002267 | 0.035359 |
GO:0032880 | regulation of protein localization | 5.83% (7/120) | 1.96 | 0.002297 | 0.035621 |
GO:0032456 | endocytic recycling | 2.5% (3/120) | 3.52 | 0.00232 | 0.035766 |
GO:0031435 | mitogen-activated protein kinase kinase kinase binding | 1.67% (2/120) | 4.76 | 0.002468 | 0.037606 |
GO:0000103 | sulfate assimilation | 1.67% (2/120) | 4.76 | 0.002468 | 0.037606 |
GO:0098588 | bounding membrane of organelle | 15.83% (19/120) | 1.02 | 0.002483 | 0.037609 |
GO:0043407 | negative regulation of MAP kinase activity | 1.67% (2/120) | 4.7 | 0.002677 | 0.039427 |
GO:0005677 | chromatin silencing complex | 1.67% (2/120) | 4.7 | 0.002677 | 0.039427 |
GO:0005791 | rough endoplasmic reticulum | 1.67% (2/120) | 4.7 | 0.002677 | 0.039427 |
GO:0007589 | body fluid secretion | 1.67% (2/120) | 4.7 | 0.002677 | 0.039427 |
GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane | 1.67% (2/120) | 4.7 | 0.002677 | 0.039427 |
GO:0061469 | regulation of type B pancreatic cell proliferation | 0.83% (1/120) | 8.35 | 0.00307 | 0.039476 |
GO:1904691 | negative regulation of type B pancreatic cell proliferation | 0.83% (1/120) | 8.35 | 0.00307 | 0.039476 |
GO:0002083 | 4-hydroxybenzoate decaprenyltransferase activity | 0.83% (1/120) | 8.35 | 0.00307 | 0.039476 |
GO:0008412 | 4-hydroxybenzoate octaprenyltransferase activity | 0.83% (1/120) | 8.35 | 0.00307 | 0.039476 |
GO:0047293 | 4-hydroxybenzoate nonaprenyltransferase activity | 0.83% (1/120) | 8.35 | 0.00307 | 0.039476 |
GO:0005164 | tumor necrosis factor receptor binding | 0.83% (1/120) | 8.35 | 0.00307 | 0.039476 |
GO:0007250 | activation of NF-kappaB-inducing kinase activity | 0.83% (1/120) | 8.35 | 0.00307 | 0.039476 |
GO:0030323 | respiratory tube development | 0.83% (1/120) | 8.35 | 0.00307 | 0.039476 |
GO:0031996 | thioesterase binding | 0.83% (1/120) | 8.35 | 0.00307 | 0.039476 |
GO:0032813 | tumor necrosis factor receptor superfamily binding | 0.83% (1/120) | 8.35 | 0.00307 | 0.039476 |
GO:0007077 | mitotic nuclear membrane disassembly | 0.83% (1/120) | 8.35 | 0.00307 | 0.039476 |
GO:0036148 | phosphatidylglycerol acyl-chain remodeling | 0.83% (1/120) | 8.35 | 0.00307 | 0.039476 |
GO:0004348 | glucosylceramidase activity | 0.83% (1/120) | 8.35 | 0.00307 | 0.039476 |
GO:0006680 | glucosylceramide catabolic process | 0.83% (1/120) | 8.35 | 0.00307 | 0.039476 |
GO:0046477 | glycosylceramide catabolic process | 0.83% (1/120) | 8.35 | 0.00307 | 0.039476 |
GO:0005813 | centrosome | 4.17% (5/120) | 2.4 | 0.002717 | 0.03957 |
GO:0055088 | lipid homeostasis | 4.17% (5/120) | 2.4 | 0.002717 | 0.03957 |
GO:0005783 | endoplasmic reticulum | 10.83% (13/120) | 1.28 | 0.002747 | 0.03979 |
GO:0070592 | cell wall polysaccharide biosynthetic process | 3.33% (4/120) | 2.79 | 0.002811 | 0.040494 |
GO:0120036 | plasma membrane bounded cell projection organization | 4.17% (5/120) | 2.38 | 0.002832 | 0.040569 |
GO:0008289 | lipid binding | 5.83% (7/120) | 1.9 | 0.002868 | 0.040869 |
GO:0046473 | phosphatidic acid metabolic process | 1.67% (2/120) | 4.65 | 0.002895 | 0.041023 |
GO:0043549 | regulation of kinase activity | 4.17% (5/120) | 2.37 | 0.00291 | 0.041024 |
GO:0050708 | regulation of protein secretion | 2.5% (3/120) | 3.35 | 0.003275 | 0.041912 |
GO:0007548 | sex differentiation | 1.67% (2/120) | 4.54 | 0.003353 | 0.042091 |
GO:0018230 | peptidyl-L-cysteine S-palmitoylation | 1.67% (2/120) | 4.54 | 0.003353 | 0.042091 |
GO:0018231 | peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine | 1.67% (2/120) | 4.54 | 0.003353 | 0.042091 |
GO:0015075 | ion transmembrane transporter activity | 8.33% (10/120) | 1.47 | 0.003377 | 0.04219 |
GO:0034220 | ion transmembrane transport | 7.5% (9/120) | 1.6 | 0.003059 | 0.042445 |
GO:0006643 | membrane lipid metabolic process | 3.33% (4/120) | 2.76 | 0.00303 | 0.04249 |
GO:0048856 | anatomical structure development | 30.83% (37/120) | 0.63 | 0.003048 | 0.042511 |
GO:0005524 | ATP binding | 11.67% (14/120) | 1.19 | 0.003339 | 0.042515 |
GO:0044038 | cell wall macromolecule biosynthetic process | 3.33% (4/120) | 2.7 | 0.003503 | 0.043355 |
GO:0070589 | cellular component macromolecule biosynthetic process | 3.33% (4/120) | 2.7 | 0.003503 | 0.043355 |
GO:0047262 | polygalacturonate 4-alpha-galacturonosyltransferase activity | 1.67% (2/120) | 4.49 | 0.003594 | 0.044069 |
GO:0001845 | phagolysosome assembly | 1.67% (2/120) | 4.49 | 0.003594 | 0.044069 |
GO:0010383 | cell wall polysaccharide metabolic process | 4.17% (5/120) | 2.29 | 0.003689 | 0.045016 |
GO:0004712 | protein serine/threonine/tyrosine kinase activity | 2.5% (3/120) | 3.27 | 0.003778 | 0.045475 |
GO:0008324 | cation transmembrane transporter activity | 6.67% (8/120) | 1.68 | 0.003747 | 0.045513 |
GO:0065009 | regulation of molecular function | 11.67% (14/120) | 1.17 | 0.003777 | 0.04567 |
GO:0019706 | protein-cysteine S-palmitoyltransferase activity | 1.67% (2/120) | 4.44 | 0.003843 | 0.045843 |
GO:0032555 | purine ribonucleotide binding | 13.33% (16/120) | 1.07 | 0.003841 | 0.046018 |
GO:0010632 | regulation of epithelial cell migration | 2.5% (3/120) | 3.23 | 0.004101 | 0.047414 |
GO:0000266 | mitochondrial fission | 1.67% (2/120) | 4.39 | 0.0041 | 0.047614 |
GO:0031489 | myosin V binding | 1.67% (2/120) | 4.39 | 0.0041 | 0.047614 |
GO:0019707 | protein-cysteine S-acyltransferase activity | 1.67% (2/120) | 4.39 | 0.0041 | 0.047614 |
GO:0030139 | endocytic vesicle | 3.33% (4/120) | 2.63 | 0.004093 | 0.04816 |
GO:0019900 | kinase binding | 6.67% (8/120) | 1.65 | 0.004207 | 0.048219 |
GO:0018193 | peptidyl-amino acid modification | 7.5% (9/120) | 1.53 | 0.004195 | 0.048287 |
GO:0017076 | purine nucleotide binding | 13.33% (16/120) | 1.06 | 0.004086 | 0.048303 |
GO:0051128 | regulation of cellular component organization | 12.5% (15/120) | 1.11 | 0.004079 | 0.048439 |
GO:0048666 | neuron development | 2.5% (3/120) | 3.2 | 0.004325 | 0.049359 |
GO:0032024 | positive regulation of insulin secretion | 1.67% (2/120) | 4.35 | 0.004365 | 0.049381 |
GO:0010048 | vernalization response | 1.67% (2/120) | 4.35 | 0.004365 | 0.049381 |
GO:0140694 | non-membrane-bounded organelle assembly | 4.17% (5/120) | 2.23 | 0.004443 | 0.049841 |